V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10389303 | 10072986 | 1.53 | 89.8 | Palliative (P) | 2019-05-06 | 2019-05-06 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101789811 |
| 10390166 | 10072987 | 1.74 | 59.8 | Neo-adjuvant (N) | 2021-09-24 | 2021-12-17 | GEMCITABINE | 02 | N | GEMCITABINE | 100576185 |
| 10393881 | 10072992 | 1.67 | 98 | 03 | 2018-11-02 | 2019-02-02 | Azacitidine | 2 | N | AZACITIDINE | 101109475 |
| 10394092 | 10072993 | 1.79 | 73.4 | null | 2022-05-01 | 2022-05-13 | Cabazitaxel | null | null | CABAZITAXEL | 101218214 |
| 10397323 | 10072995 | 1.68 | 64.1 | Adjuvant (A) | 2017-11-16 | 2017-11-17 | Azacitidine | 02 | N | AZACITIDINE | 101420043 |
| 10399803 | 10072996 | 1.73 | 70 | Palliative (P) | 2021-01-30 | 2021-01-31 | Niraparib | 02 | N | CABOZANTINIB | 100479259 |
| 10404444 | 10072998 | 1.66 | 52 | 03 | 2021-01-28 | 2021-05-11 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | N | CISPLATIN | 101732737 |
| 10404614 | 10072999 | 1.94 | 57.8 | Disease modification (D) | 2019-09-22 | 2019-09-26 | Azacitidine | 02 | N | AZACITIDINE | 101714696 |
| 10409542 | 10073000 | 1.64 | 68.4 | Palliative (P) | 2020-10-30 | 2021-10-06 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 100586671 |
| 10414088 | 10073001 | 1.67 | 76.3 | Palliative (P) | 2019-09-29 | 2019-09-29 | CVP R | 02 | N | NIRAPARIB | 101747330 |
| 10415900 | 10073003 | 1.74 | null | 03 | 2020-05-02 | 2020-05-04 | BUSULFAN | 02 | null | CISPLATIN | 101412971 |
| 10421926 | 10073005 | 1.67 | 64.1 | Palliative (P) | 2020-05-20 | 2020-06-14 | Palbociclib | 02 | N | PALBOCICLIB | 101205507 |
| 10422545 | 10073006 | 1.85 | 90 | 03 | 2017-11-16 | 2018-06-14 | PERTUZUMAB + TRASTUZUMAB | 99 | N | ACALABRUTINIB | 101696199 |
| 10425272 | 10073009 | null | null | null | 2019-07-13 | 2019-08-05 | Pemetrexed | 02 | null | IDELALISIB + RITUXIMAB | 100998880 |
| 10425742 | 10073010 | null | null | null | 2019-11-09 | 2020-06-06 | CARBOPLATIN + FLUOROURACIL | 02 | null | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101324934 |
| 10425811 | 10073011 | 1.85 | null | null | 2022-05-18 | 2022-05-19 | TRANSPLANT CARMUSTINE + THIOTEPA | null | null | LUTETIUM-177 | 100147381 |
| 10426029 | 10073012 | 1.6 | 82.3 | null | 2019-02-15 | 2019-03-17 | AML 18 TRIAL | null | null | AML18 TRIAL | 101147227 |
| 10426523 | 10073014 | 1.77 | 88 | null | 2018-09-08 | 2018-10-12 | null | null | null | PEMETREXED | 100706425 |
| 10427505 | 10073016 | 1.66 | 62 | Curative (C) | 2021-08-02 | 2021-08-23 | Lomustine | Y | N | UKALL60+ | 100477650 |
| 10431192 | 10073020 | 1.66 | 63.4 | null | 2022-04-07 | 2022-04-14 | TRASTUZUMAB EMTANSINE | 02 | null | ERIBULIN | 101121873 |
| 10436800 | 10073022 | 1.79 | 59.35 | null | 2018-04-26 | 2018-04-26 | Olaparib | null | null | BOSUTINIB | 101460756 |
| 10438324 | 10073023 | 1.68 | 102.3 | Curative (C) | 2021-05-21 | 2021-05-28 | Gemcitabine + Capecitabine | 02 | N | ANASTROZOLE + PALBOCICLIB | 101721919 |
| 10439306 | 10073024 | 1.76 | 78.6 | Curative (C) | 2018-09-04 | 2018-09-04 | Bexarotene | 02 | N | DOXORUBICIN EMBOLISATION | 101529428 |
| 10444165 | 10073025 | 1.74 | 0 | null | 2019-09-04 | 2019-09-04 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | null | EVEROLIMUS | 100926689 |
| 10444770 | 10073026 | 1.78 | 57.5 | null | 2015-08-10 | 2021-11-02 | CHOP R - 21 days | 02 | null | PEG INTERFERON | 101371771 |
| 10449361 | 10073027 | 1.68 | 0 | null | 2020-07-18 | 2020-07-18 | FLAIR trial | 02 | null | CYCLOPHOSPHAMIDE + IDARUBICIN | 101620296 |
| 10456315 | 10073029 | 1.69 | 83 | Palliative (P) | 2021-01-18 | 2021-02-13 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 02 | N | MITOMYCIN INTRAVESICULAR | 100751880 |
| 10461875 | 10073031 | 0 | 63.6 | Palliative (P) | null | 2018-06-19 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 99 | N | CYTARABINE HIGH DOSE | 101721378 |
| 10465757 | 10073034 | null | null | null | 2021-11-04 | 2021-12-18 | Apalutamide | 02 | null | CHLORAMBUCIL + RITUXIMAB | 101283390 |
| 10468857 | 10073036 | 1.56 | 80.6 | Curative (C) | 2020-02-22 | 2020-02-29 | Cisplatin + Radiotherapy | 99 | N | CAPECITABINE + CISPLATIN | 101815249 |
| 10472643 | 10073039 | null | 58.7 | null | 2021-07-31 | 2021-08-16 | PCV | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100471881 |
| 10473818 | 10073042 | 0 | 72 | Adjuvant (A) | 2019-12-13 | 2019-12-13 | null | 02 | N | CHOP R | 101654071 |
| 10480204 | 10073046 | 1.7 | 75.8 | Curative (C) | 2021-11-17 | 2022-01-13 | R GCVP | 2 | N | MYELOMA XI TRIAL | 101850637 |
| 10186892 | 10073050 | null | null | Adjuvant (A) | 2018-10-07 | 2018-10-12 | Cetuximab + Encorafenib | 02 | N | BEXAROTENE | 100272932 |
| 10194595 | 10073052 | null | 79.1 | null | 2018-09-08 | 2020-01-18 | ABEMACICLIB + FULVESTRANT | 02 | null | BENDAMUSTINE + OBINUTUZUMAB | 100647434 |
| 10240488 | 10073054 | 1.63 | 84.4 | Palliative (P) | 2019-11-23 | 2019-12-05 | null | 02 | null | BRENTUXIMAB | 101791713 |
| 10245092 | 10073055 | 1.73 | 93.3 | Palliative (P) | 2018-09-20 | 2018-09-20 | Trial Unspecified | 02 | N | ANAGRELIDE | 100537325 |
| 10257267 | 10073056 | 1.7 | 69 | Palliative (P) | null | 2021-04-08 | DHAP - R | 02 | N | BEXAROTENE | 101351999 |
| 10257579 | 10073057 | 1.7 | 89.3 | Palliative (P) | 2020-04-07 | 2022-05-01 | DOCETAXEL + TRASTUZUMAB | 02 | N | CARBOPLATIN + FLUOROURACIL | 101654023 |
| 10280266 | 10073059 | 1.82 | 0 | null | 2019-04-12 | 2019-05-04 | Sunitinib | 02 | null | CYTARABINE | 100528963 |
| 10285735 | 10073060 | 1.73 | 70.5 | null | 2019-11-14 | 2019-11-26 | Bevacizumab 7.5mg/kg | 02 | null | CARFILZOMIB | 100919886 |
| 10297559 | 10073061 | 1.68 | 0 | Palliative (P) | null | 2021-04-08 | Dasatinib | 02 | N | SORAFENIB | 100394923 |
| 10302602 | 10073063 | null | 46.1 | Palliative (P) | 2020-03-26 | 2020-04-15 | Cape+Cetuximab+Oxalip (2 wk) Maint | 02 | N | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100733846 |
| 10335464 | 10073066 | 1.68 | 71.75 | null | 2020-11-24 | 2020-12-09 | CYCLOPHOSPHAMIDE + IDARUBICIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100837378 |
| 10337274 | 10073067 | 0 | 92 | null | null | 2020-02-05 | FEC + DOCETAXEL | 02 | null | DURVALUMAB | 100832100 |
| 10381938 | 10073071 | 1.6 | 45.1 | null | 2021-10-07 | 2021-10-08 | Paclitaxel albumin (Abraxane) 21day | 02 | null | ABEMACICLIB | 101748891 |
| 10384782 | 10073072 | 1.6 | 60.7 | Palliative (P) | 2019-01-29 | 2019-06-01 | CAPECITABINE + CARBOPLATIN + Trastuzumab | 02 | N | CVP R | 100920432 |
| 10391097 | 10073073 | 0 | 66.7 | Curative (C) | 2021-09-07 | 2021-10-26 | Irinotecan 14day | 02 | N | UKALL60+ | 101266589 |
| 10407907 | 10073074 | 1.66 | 73.6 | Palliative (P) | 2020-07-20 | 2020-07-25 | Alectinib | N | N | CISPLATIN + PEMETREXED | 100734335 |
| 10431345 | 10073076 | 1.93 | 81.15 | null | 2018-02-23 | 2018-02-26 | Cytarabine High Dose | 02 | null | ETOPOSIDE | 101540212 |